HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,422 | +173.1% | 29,276 | +180.9% | 0.02% | +142.9% |
| Q2 2023 | $887 | -78.7% | 10,423 | -79.3% | 0.01% | -79.4% |
| Q1 2023 | $4,157 | +39.4% | 50,232 | +32.5% | 0.03% | -20.9% |
| Q4 2022 | $2,981 | -99.0% | 37,900 | +561.9% | 0.04% | +1333.3% |
| Q4 2021 | $304,000 | -54.5% | 5,726 | -4.8% | 0.00% | -70.0% |
| Q1 2021 | $668,000 | -85.4% | 6,015 | -84.4% | 0.01% | -77.8% |
| Q4 2020 | $4,570,000 | -27.9% | 38,488 | -47.0% | 0.04% | -64.6% |
| Q3 2020 | $6,339,000 | +84.3% | 72,659 | +89.2% | 0.13% | +42.7% |
| Q2 2020 | $3,439,000 | -10.5% | 38,401 | +14.8% | 0.09% | +23.6% |
| Q4 2019 | $3,842,000 | – | 33,437 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |